{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All+Cause+Mortality&page=2", "query": { "condition": "All Cause Mortality", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All+Cause+Mortality&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T17:20:45.582Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00756964", "title": "Lowering Serum Uric Acid to Prevent Acute Kidney Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperuricemia" ], "interventions": [ { "name": "Rasburicase", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2008-10", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2012-09-03", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00756964" }, { "nct_id": "NCT01989195", "title": "Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "ISCHEMIC CARDIOMYOPATHY" ], "interventions": [ { "name": "'SEEMORE' - MANGANESE-ENHANCED MRI CONTRAST REAGENT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 6, "start_date": "2013-05", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2017-01-02", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01989195" }, { "nct_id": "NCT00037687", "title": "Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sepsis" ], "interventions": [ { "name": "rPAF-AH", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ICOS Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2500, "start_date": "2001-04", "completion_date": "2004-12", "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 1, "location_summary": "Bothell, Washington", "locations": [ { "city": "Bothell", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00037687" }, { "nct_id": "NCT06183931", "title": "Study of ALXN2220 Versus Placebo in Adults With ATTR-CM", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Transthyretin Amyloid Cardiomyopathy" ], "interventions": [ { "name": "ALXN2220", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 1181, "start_date": "2024-01-11", "completion_date": "2028-04-05", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 36, "location_summary": "Irvine, California • La Jolla, California • Palo Alto, California + 30 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06183931" }, { "nct_id": "NCT00558311", "title": "Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Aneurysmal Subarachnoid Hemorrhage" ], "interventions": [ { "name": "Clazosentan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Idorsia Pharmaceuticals Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1157, "start_date": "2007-12-14", "completion_date": "2010-07-13", "has_results": false, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Englewood, Colorado • Boston, Massachusetts + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00558311" }, { "nct_id": "NCT00940095", "title": "Clazosentan in Aneurysmal Subarachnoid Hemorrhage", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Aneurysmal Subarachnoid Hemorrhage" ], "interventions": [ { "name": "Clazosentan 5 m/h", "type": "DRUG" }, { "name": "Clazosentan 15 mg/h", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Idorsia Pharmaceuticals Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 577, "start_date": "2009-07-01", "completion_date": "2011-01-01", "has_results": false, "last_update_posted_date": "2018-07-09", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 29, "location_summary": "Glendale, California • San Francisco, California • Stanford, California + 21 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00940095" }, { "nct_id": "NCT02043691", "title": "Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Juxtarenal Aortic Aneurysm", "Suprarenal Aortic Aneurysm", "Thoracoabdominal Aortic Aneurysm", "Penetrating Aortic Ulcer", "Aortic Arch Aneurysm", "Aortic Dissection" ], "interventions": [ { "name": "Cook Custom Aortic Endograft", "type": "DEVICE" }, { "name": "Zenith t-Branch Endovascular Graft", "type": "DEVICE" }, { "name": "Surgeon-Modified Endograft", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 410, "start_date": "2014-06", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02043691" }, { "nct_id": "NCT07563777", "title": "100-Year Human Aging Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aging", "Aging Well", "All-Cause Mortality", "Mortality", "Metabolic Syndrome", "Cardiovascular Diseases", "Cognitive Dysfunction", "Musculoskeletal Diseases", "Neoplasms", "Frailty", "Activities of Daily Living", "Health-Related Quality of Life", "Disability Physical", "Neuro-Degenerative Disease", "Dementia" ], "interventions": [ { "name": "Comprehensive Multi-System Clinical Screening", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Longevity Metrics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000000, "start_date": "2025-02-09", "completion_date": "2099-12-31", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 1, "location_summary": "Boulder, Colorado", "locations": [ { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07563777" }, { "nct_id": "NCT00358215", "title": "RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure", "Anemia", "Cardiovascular Disease", "Ventricular Dysfunction", "Congestive Heart Failure" ], "interventions": [ { "name": "Darbepoetin alfa", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2278, "start_date": "2006-06-01", "completion_date": "2012-10-11", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 254, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 195 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358215" }, { "nct_id": "NCT00963989", "title": "Imaging Guided Patient Selection for Interventional Revascularization Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Ischemic Stroke" ], "interventions": [ { "name": "Penumbra System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Penumbra Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 146, "start_date": "2009-09", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2021-11-23", "last_synced_at": "2026-09-23T17:20:45.582Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00963989" } ] }